ArticleBMC biotechnology2021

Insights from molecular docking and molecular dynamics on the potential of vitexin as an antagonist candidate against lipopolysaccharide (LPS) for microglial activation in neuroinflammation.

M A F Yahaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.